Cited by ..

The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer

Fan Cheng, Patricia J McLaughlin, Michael F Verderame, Ian S Zagon

Mol Cancer. 2008; 7: 5. Published online 2008 January 11. doi: 10.1186/1476-4598-7-5

PMCID:: PMC2253554

Abstract Full Text PDF–676K Supplementary Material

Is Cited by the Following 4 Articles in this Archive:

Galectin-1 and Its Involvement in Hepatocellular Carcinoma Aggressiveness

Daniela Spano, Roberta Russo, Vittorio Di Maso, Natalia Rosso, Luigi M Terracciano, Massimo Roncalli, Luigi Tornillo, Mario Capasso, Claudio Tiribelli, Achille Iolascon

Mol Med. 2010 Mar-Apr; 16(3-4): 102–115. Published online 2009 December 21. doi: 10.2119/molmed.2009.00119

PMCID:: PMC2829614

Abstract Full Text PDF–3.0M

The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer

Diego M. Avella, Eric T. Kimchi, Renee N. Donahue, Hephzibah Rani S. Tagaram, Patricia J. McLaughlin, Ian S. Zagon, Kevin F. Staveley-O'Carroll

Am J Physiol Regul Integr Comp Physiol. 2010 February; 298(2): R459–R466. Published online 2009 November 18. doi: 10.1152/ajpregu.00646.2009

PMCID:: PMC2828179

Abstract Full Text

Diabetic Keratopathy and Treatment by Modulation of the Opioid Growth Factor (OGF) - OGF Receptor (OGFr) Axis With Naltrexone: A Review

Patricia J. McLaughlin, Joseph W. Sassani, Matthew S. Klocek, Ian S. Zagon

Brain Res Bull. Author manuscript; available in PMC 2011 February 15.

Published in final edited form as: Brain Res Bull. 2010 February 15; 81(2-3): 236–247. Published online 2009 August 14. doi: 10.1016/j.brainresbull.2009.08.008